1. Home
  2. GALT vs INSW Comparison

GALT vs INSW Comparison

Compare GALT & INSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GALT
  • INSW
  • Stock Information
  • Founded
  • GALT 2000
  • INSW 1999
  • Country
  • GALT United States
  • INSW United States
  • Employees
  • GALT N/A
  • INSW N/A
  • Industry
  • GALT Biotechnology: Pharmaceutical Preparations
  • INSW Semiconductors
  • Sector
  • GALT Health Care
  • INSW Technology
  • Exchange
  • GALT Nasdaq
  • INSW Nasdaq
  • Market Cap
  • GALT 83.5M
  • INSW 1.8B
  • IPO Year
  • GALT N/A
  • INSW N/A
  • Fundamental
  • Price
  • GALT $2.80
  • INSW $38.75
  • Analyst Decision
  • GALT Buy
  • INSW Buy
  • Analyst Count
  • GALT 2
  • INSW 2
  • Target Price
  • GALT $6.00
  • INSW $52.00
  • AVG Volume (30 Days)
  • GALT 1.5M
  • INSW 704.9K
  • Earning Date
  • GALT 08-12-2025
  • INSW 08-06-2025
  • Dividend Yield
  • GALT N/A
  • INSW 10.40%
  • EPS Growth
  • GALT N/A
  • INSW N/A
  • EPS
  • GALT N/A
  • INSW 6.47
  • Revenue
  • GALT N/A
  • INSW $860,606,000.00
  • Revenue This Year
  • GALT N/A
  • INSW N/A
  • Revenue Next Year
  • GALT N/A
  • INSW $1.88
  • P/E Ratio
  • GALT N/A
  • INSW $5.95
  • Revenue Growth
  • GALT N/A
  • INSW N/A
  • 52 Week Low
  • GALT $0.73
  • INSW $27.20
  • 52 Week High
  • GALT $3.90
  • INSW $58.73
  • Technical
  • Relative Strength Index (RSI)
  • GALT 67.38
  • INSW 51.76
  • Support Level
  • GALT $2.07
  • INSW $38.59
  • Resistance Level
  • GALT $2.36
  • INSW $40.40
  • Average True Range (ATR)
  • GALT 0.24
  • INSW 1.22
  • MACD
  • GALT 0.03
  • INSW 0.00
  • Stochastic Oscillator
  • GALT 81.11
  • INSW 61.64

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

About INSW International Seaways Inc.

International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. The fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.

Share on Social Networks: